|
Ben Westhoff, Award-Winning Investigative Reporter Specializing in Fentanyl to Speak at Meet Delic: The World's Premiere Psychedelic & Wellness Event
|
|
Delic Holdings Corp.
|
Aug 24, 2021 02:00AM
|
|
Bloom Health Partners Announces Contract for COVID Testing in Alabama Schools
|
|
Bloom Health Partners
|
Nov 29, 2021 08:30AM
|
|
Bloom Health Partners Announces Contract With State of Texas For K-12 Schools
|
|
Bloom Health Partners
|
Jan 18, 2022 08:30AM
|
|
Bloom Health Partners Announces New Facilities to Serve New York and Northeastern US Regional Clients
|
|
Bloom Health Partners
|
Jan 06, 2022 08:30AM
|
|
Bloom Health Partners Announces Upgrade to the OTCQB Markets and Atlanta Expansion
|
|
Bloom Health Partners
|
Nov 17, 2021 08:30AM
|
|
Bloom Health Partners Corporate Update
|
|
Bloom Health Partners
|
Nov 04, 2021 08:30AM
|
|
Bloom Health Partners Receives DTC Eligibility
|
|
Bloom Health Partners
|
Jan 20, 2022 08:30AM
|
|
BNN Bloomberg: "53% of Canadians on the brink of insolvency: MNP survey"
|
|
Inverite Insights
|
Apr 08, 2021 02:29PM
|
|
Brittany Hoogenboom, Founder of Synergy Soul and Holistic Business Coach, To Headline At Meet Delic: The World's Premiere Psychedelic & Wellness Event
|
|
Delic Holdings Corp.
|
Oct 19, 2021 02:00AM
|
|
Cardiol Therapeutics Announces $15 Million Bought Deal Public Offering
|
|
Cardiol Theraputics Inc.
|
May 05, 2021 04:34PM
|
|
Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants Issued on June 4, 2020
|
|
Cardiol Theraputics Inc.
|
Sep 10, 2021 04:33PM
|
|
Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A
|
|
Cardiol Theraputics Inc.
|
Apr 01, 2021 08:44AM
|
|
Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial...
|
|
Cardiol Theraputics Inc.
|
Jan 21, 2021 07:27AM
|
|
Cardiol Therapeutics Announces Pricing of Public Offering of Units
|
|
Cardiol Theraputics Inc.
|
Nov 03, 2021 08:36AM
|
|
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx(TM)
|
|
Cardiol Theraputics Inc.
|
Apr 12, 2021 07:40AM
|
|
Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical Officer
|
|
Cardiol Theraputics Inc.
|
Mar 30, 2021 07:03AM
|
|
Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory Board
|
|
Cardiol Theraputics Inc.
|
Jan 19, 2022 07:27AM
|
|
Cardiol Therapeutics Closes $22 Million Bought Deal Offering
|
|
Cardiol Theraputics Inc.
|
May 12, 2021 09:03AM
|
|
Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx(TM), into Brazil, Mexico, and Canada
|
|
Cardiol Theraputics Inc.
|
Oct 18, 2021 07:27AM
|
|
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Units
|
|
Cardiol Theraputics Inc.
|
Nov 02, 2021 04:04PM
|
